Discipline

Pediatric Hematologist/Oncologist

Research Department

Pediatric Oncology

Interests

Late effects of pediatric cancer, Retinoblastoma, Solid tumors, Wilms tumor, Neuroblastoma, Cancer predisposition

Biography

Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Children's Hospital Cancer Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Children's Hospital Boston. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Children's Hospital Boston and did her subspecialty training at Dana-Farber/Children's Hospital Boston where she has been on the faculty for 19 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.

Background

Board Certification
Pediatric Hematology/Oncology
Pediatrics

Fellowship
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 07/88 to 06/91

Residency
Boston Children's Hospital, Pediatrics, 07/86 to 06/88

Internship
Children's Hospital Boston, 07/85 to 06/86

Medical School
University of California, San Diego School of Medicine, 1985

Recent Awards

• Stephen E. Sallan Leadership award, 2004
• Benacerraf-Frei Investigator, DFCI, 1998
• Dyson Scholar Award, DFCI, 1998